The Royal Society of Medicine is pleased to announce it will be hosting its 17th Medical Innovations Summit on Saturday 29th September 2018. Information on the speakers at the 17th summit will be announced here. You can watch the presentations from the previous summits through our RSM Videos website here which showcases innovators we have been privileged to host in the past.
Bookings for the 17th Medical Innovations Summit are now open, speakers will be announced below in the lead up to the day.
The Royal Society of Medicine is delighted that the 17th medical innovations summit will be hosted by Professor Gillian Leng. Not only is Professor Leng a RSM Fellow and Trustee, in her day job, she is the Deputy Chief Executive of NICE.
Three years ago a decision was made to create a united, single leadership for health and social care across Greater Manchester – to ensure the greatest and fastest possible improvement to the health and wellbeing of the 2.8million residents. Working closely with senior health, social care and council leaders from across the region, Jon Rouse is overseeing a new era for Greater Manchester, as it takes charge of a £6billion health and social care budget. Hear about the extraordinary and innovative progress Greater Manchester is making and how can other cities and regions learn from this unusual new approach.
There are over 34,000 GPs in the UK. They are for the most of us the first port of call. Yet they only have 10 minutes for each patient, and with increasing numbers retiring early and fewer junior doctors wanting to become general practitioners, what is the future of primary care? Can innovation help GPs see more patients, provide a better service and keep patients (often with chronic conditions) at home and away from hospitals?
Dr Grimes has led award-winning projects including ’MyLittleOne’, a neonatal camera and tablet system, and Brighton and Hove Roving GP service. He is currently engaged with ‘See What I See’, an evaluation of Google Glass for remote consultations. Keith is Clinical Innovation Director at Babylon Health, a GP and founder of VR Doctors.
Hailed as ‘enormously significant’, results in a groundbreaking trial are the first time a drug has been shown to suppress effects of Huntington’s genetic mutation. Huntington’s disease is an inherited or genetic disorder of the central nervous system and there are approx 6,700 patients in the UK with the disease. Professor Tabrizi, co-founder of University College London’s Huntingdon Disease Centre recently reported at a conference in Los Angeles in April, significant results for a first-in-human, multicentre, double-blind study. The results of the trial have also caused ripples of excitement across the scientific world because the drug, which is a synthetic strand of DNA, could potentially be adapted to target other incurable brain disorders such as Alzheimer’s and Parkinson’s.
In 2010 the Marmot Review was commissioned by government to propose strategies to reduce health inequalities. Marmot found that around 70% of health outcomes are determined by social factors, and just 30% by clinical interventions. As a result ‘social prescribing’ has been a hugely successful development in recent years, yet its profile remains low. Sir Sam Everington, a practising, longstanding and pioneering GP (and chair of Tower Hamlets CCG), will speak about the benefits of social prescribing and the success achieved at the innovative Bromley-by-Bow Centre.
The Department of Health & Social Care set up Genomics England in 2013. Their aim is to deliver the 100,000 Genomes Project. Sequencing 100,000 DNA codes of patients should lead to better, earlier diagnosis and personalised care, for cancer, rare diseases and infectious diseases. Professor Joanne Hackett is their Chief Commercial Officer and will explain the extraordinary value of the largest data set of its kind in the world, how companies and other institutions can access the data and will open a conversation about the value of striking a partnership with Genomics England.
How close are we to looking into the sky and seeing ‘medical’ drones travelling in British skies? In a recent and impressive report by Nesta called ‘Flying High’, detailed research has been published about drones travelling between hospitals. Case studies have been worked up in London, Southampton & the Isle of Wight, the West Midlands and in Bradford. Kathy Nothstine, Nesta’s lead on Future Cities will explain the logistics, social benefits, financial incentives and challenges of drone technology.
Toilets change everything. They keep girls in school, reduce childhood mortality, prevent disease, increase productivity and keep cities clean. The co-founder of 'Gather', Lindsey Noakes will explain how 'Gather' brings people and data together to help solve the urban sanitation crisis. By 2020, Gather wants to expand sanitation services for 15 million people in eight emerging cities across the world. This is critically important given the extraordinary statistic that over 4.5 billion people do not have access to sanitation.
Scientists have discovered that it is possible to identify people at high risk of developing acute myeloid leukaemia (AML), years before diagnosis. AML is an aggressive blood cancer that affects people of all ages. Dr Grace Collord is the joint first author on the paper from the Wellcome Sanger Institute and University of Cambridge.
Currently, there is no cure for eczema. Finding a cure would significantly transform the lives of over 6 million sufferers in the UK and 230 million people globally. The biotechnology company Kymab, based in Cambridge, announced in July, positive results from their first human trials. Kymab’s technology has caught the eye of investors and in late 2016 the company secured $ 100million. Dr Sonia Quaratino, the company’s Chief Medical Officer will talk about their success to date and their plans to use their technology to tackle illnesses such as arthritis, multiple sclerosis and lupus.
Hear about how a small dedicated team of surgeons, obstetricians, anaesthetists, neonatologists and midwives perform miracles at The East Midlands Congenital Heart Centre at Glenfield Hospital in Leicester. Consultant paediatric cardiologist Dr Frances Bu’lock will be speaking about how her colleagues managed the birth of Vanellope Hope Wilkins who, before birth, was missing a breastbone and her heart was growing outside her body. And if that wasn’t challenging enough, at the same time, the heart centre was under threat of closure.
One of many talented students to have graduated in the Summer is Folashade Oyewole who has just completed her MBBS at Imperial College Medical School. She completed a degree in Medical sciences with management, whilst studying medicine. Dr Oyewole will make some closing remarks and give the Vote of Thanks at the end of the Medical Innovations Summit.
The Royal Society of Medicine
1 Wimpole Street, London W1G 0AE
T: +44(0)20 7290 3919
Professor Gillian Leng CBE, MD
Trustee of the RSM and Deputy Chief Executive at NICE, the National Institute for Health and Care Excellence.
At the private lunch for speakers, the RSM is delighted to host Melanie Nana and Holly Morgan, Specialist Registrars in Endocrinology and Cardiology, based in Wales. They are leading an initiative to better educate Trainees and recently won an Excellence in Patients Care Award.
Find out about which innovators the RSM has hosted since the programme began in 2008.See past innovators